8 October 2026 Rival Halozyme secures a major patent victory against the pharma giant, blocking the subcutaneous version of ...
29 September 2026 As partner and head of IP for the region, the Hong Kong-based hire brings extensive experience advising on ...
Rival Halozyme secures a major patent victory against the pharma giant, blocking the subcutaneous version of its blockbuster ...
2 October 2026 AI is helping legal and IP teams handle more work without adding headcount, but in-house counsel at LSPN ...
Based in Munich, Germany, the new principal—who brings SEP licensing and trade secret expertise—will help grow the firm’s cross-border capabilities across Europe. If you don't have a login or your ...
Tapio Blanc, chief trademark officer at Roche, explains why fighting fakes can be a matter of life and death, and how AI, ...
1 October 2026 The decision leaves a $177 million verdict against Lilly intact, but a dissenting judge has warned the ruling ...
The decision leaves a $177 million verdict against Lilly intact, but a dissenting judge has warned the ruling could ...
With patent validity increasingly being fought over in both the UPC and EPO, Genevant Sciences’ Stephan Kutik talks to LSIPR ...
Can a drug’s ‘inactive’ precursor qualify for a multi-million pound patent extension? The UK High Court has just delivered a ...
The Third Circuit has upheld Thomson Reuters’ victory over Ross Intelligence in the first US appellate ruling on whether AI ...